Offstream
news

---

Changes

1. Turkey receives 6.5 million doses of the vaccine made by Sinovac Biotech.
   2021-01-26 03:05:33 (First version)
2. Turkey receives 6.5 million doses of the Sinovac Biotech vaccine.
   (Current version)

---

Related

North Macedonia receives 30,000 doses of Sinovac CoronaVac vaccine donated by Turkey.
2021-06-9

Thailand's Food and Drug Administration grants emergency use authorization for the Sinovac Biotech CoronaVac vaccine.
2021-02-22

President Recep Tayyip Erdoğan and health workers across the country receive their second doses of COVID-19 vaccine as the country begins to administer second doses of Sinovac's CoronaVac vaccine.
2021-02-11

President Recep Tayyip Erdoğan receives the first dose of the CoronaVac vaccine in a hospital in Ankara as Turkey begins its nationwide vaccination campaign.
2021-01-14

Turkey approves the emergency use of the vaccine developed by Sinovac Biotech.
2021-01-13

Turkey receives their first shipment of three million doses of Sinovac's CoronaVac.
2020-12-30

Ukraine signs an agreement to buy up to 1.8 million doses of Sinovac's CoronaVac. Prime Minister Denys Shmyhal says the first shipment of vaccines could arrive in February.
2020-12-30

Turkey announces that CoronaVac is 91.25% effective in preventing COVID-19 based on data in interim studies. These initial results follow Phase III trials that involved 7,371 volunteers.
2020-12-24

Turkey purchases 50 million doses of CoronaVac to be delivered in December, January, and February, said Health Minister Fahrettin Koca.
2020-11-25

Sinovac Biotech's CoronaVac appears to be safe in providing protection against COVID-19, as preliminary results of Phase III clinical trial in Brazil show. São Paulo's Instituto Butantan, one of Brazil's leading biomedical research centres carrying out the trials, says CoronaVac proved to be safe after its two doses were applied to 9,000 volunteers, but said data on how effective it is in protecting people against COVID-19 will not be released until it has been tested on all 15,000 volunteers in newly expanded trials.
2020-10-19